Malignant neoplasm of unspecified part of left adrenal gland
ICD-10 C74.92 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified part of left adrenal gland.
C74.92 refers to a malignant neoplasm located in the left adrenal gland, which is responsible for producing hormones such as cortisol, aldosterone, and adrenaline. These hormones play crucial roles in regulating metabolism, blood pressure, and the body's response to stress. Malignant tumors in the adrenal gland can disrupt normal hormone production, leading to various metabolic disorders and endocrine dysfunctions. Symptoms may include hypertension, weight gain, and abnormal glucose metabolism. Diagnosis typically involves imaging studies such as CT or MRI scans, along with biochemical tests to assess hormone levels. Treatment often includes surgical resection of the tumor, and in some cases, adjunctive therapies such as chemotherapy or radiation may be necessary. Accurate coding is essential for proper treatment planning and reimbursement, as well as for tracking outcomes in patients with adrenal malignancies.
Detailed hormone level assessments, imaging results, and clinical symptoms.
Patients presenting with symptoms of Cushing's syndrome or adrenal insufficiency.
Ensure comprehensive documentation of all endocrine evaluations and treatment plans.
Pathology reports, imaging studies, and treatment plans including surgical and non-surgical interventions.
Patients undergoing evaluation for adrenal tumors or receiving treatment for adrenal cancer.
Document staging and grading of the tumor, as well as any metastasis.
Used when a malignant adrenal tumor is surgically removed.
Operative report detailing the procedure and findings.
Endocrinologists and oncologists should ensure accurate coding based on surgical findings.
Common symptoms include hypertension, weight gain, abnormal glucose metabolism, and signs of hormonal excess such as Cushing's syndrome or hyperaldosteronism.
